| Price | $14.00 on 13-11-2026 at 17:30:00 |
|---|---|
| Change | $0.00 0% |
| Buy | $0.00 |
| Sell | $0.00 |
| Last Trade: | Unknown 432.00 at $11.7726 |
| Day's Volume: | 432 |
| Last Close: | $14.00 |
| Open: | $14.00 |
| ISIN: | US90320U1152 |
| Day's Range | $0.00 - $0.00 |
| 52wk Range: | $13.00 - $18.50 |
| Market Capitalisation: | $5.92b |
| VWAP: | $11.7726 |
| Shares in Issue: | 422.64m |
Sector: Industrial Chemicals
Upl Limited (UPLL) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 432 | $11.7726 | OTC Trade |
09:34:20 - 13-Nov-26 |
| Unknown* | 16 | $11.6515 | OTC Trade |
08:39:14 - 12-Nov-26 |
| Unknown* | 727 | $11.9033 | OTC Trade |
07:47:06 - 11-Nov-26 |
| Unknown* | 422 | $10.6678 | OTC Trade |
10:01:00 - 02-Nov-26 |
| Buy* | 3,573 | $14.00 | Suspected BUY Trade |
08:00:22 - 02-Nov-26 |
| Unknown* | 449 | $11.3166 | OTC Trade |
11:05:04 - 16-Oct-26 |
| Unknown* | 225 | $11.0788 | OTC Trade |
11:31:56 - 13-Oct-26 |
| Unknown* | 224 | $11.0788 | OTC Trade |
11:03:17 - 13-Oct-26 |
| Unknown* | 3 | $10.6476 | OTC Trade |
10:59:18 - 01-Oct-26 |
| Unknown* | 898 | $11.6025 | OTC Trade |
10:53:50 - 23-Sep-26 |
Upl Limited (UPLL) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Nov 2026 10:18 am | RNS | Outcome of Board meeting held on November 02, 2026 |
| 26th Oct 2026 11:26 am | RNS | Intimation of Board Meeting for the Q2 and H1 FY27 |
| 6th Aug 2026 1:57 pm | RNS | Outcome of the 42nd AGM held on August 6, 2026. |
| 3rd Aug 2026 11:39 am | RNS | Financial results quarter ended June 30, 2026 |
| 3rd Aug 2026 7:00 am | RNS | Update regarding Composite Scheme of Arrangement |
| 31st Jul 2026 11:03 am | RNS | Update on Composite Scheme of Arrangement |
| 27th Jul 2026 6:21 pm | RNS | Intimation of BM Earnings Call for Q1FY27 |
| 15th Jul 2026 5:30 pm | RNS | Notice - 42nd AGM and Annual Report for FY 2025-26 |
| 25th Jun 2026 8:24 am | RNS | Intimation of AGM and Record Date for Dividend |
| 11th May 2026 9:20 am | RNS | Financial Results March 2026 |
